IL10 and breast carcinoma: High IL-10 levels predict poor breast cancer prognosis and the IL-10 secreted by TAMs can inhibit T cell effector functions and induce regulatory functions that recruit Tregs (Noy and Pollard, 2014; Ahmad et al., 2018).